Rhonda Pacheco
InvestorPresident, U.S. Business Unit and U.S. Country Head at Takeda Ventures
Greater Boston
About
Rhonda Pacheco is President of Takeda's U.S. Business Unit and U.S. Country Head and a member of Takeda's Executive Team, overseeing a portfolio that includes gastroenterology, neuroscience, plasma-derived therapies and rare diseases. She previously worked at Eli Lilly as Group Vice President of U.S. Cardiometabolic Health, where she managed product launches including Lilly's GLP-1 portfolio. She holds a Doctor of Pharmacy from the University of Rhode Island and an MBA from Duke University's Fuqua School of Business.
Experience
- TakedaPresident, U.S. Business Unit and Country Headcurrent2025 — presentCambridge, Massachusetts, United States
- Eli Lilly and CompanyGroup Vice President, Cardiometabolic Health2023 — 2025United States
- Eli Lilly and CompanyPresident and General Manager, Eli Lilly Canada Inc.2020 — 2023Toronto, Ontario, Canada
- Eli Lilly and CompanyGlobal Brand Development Leader, Immunology2018 — 2020Indianapolis, Indiana
- Eli Lilly and CompanySr Director of Sales - New England2016 — 2018Greater Boston Area
- Eli Lilly and CompanyGlobal Brand Director2016Indianapolis, Indiana Area
- Eli Lilly and CompanySales & Marketing Business Unit Director, South Africa & Sub-Saharan Africa2013 — 2015Johannesburg Area, South Africa
- Eli Lilly and CompanyDistrict Sales Manager2011 — 2013Washington D.C. Metro Area
- Career BreakProfessional development2009 — 2011Raleigh-Durham-Chapel Hill Area
- Eli Lilly and CompanyBrand Manager, Senior Consultant2007 — 2009
- Eli Lilly and CompanySenior Trainer2006 — 2007United States
- Eli Lilly and CompanyManaged Care Senior Account Executive2003 — 2006Washington D.C. Metro Area
Education
- Duke University - The Fuqua School of BusinessMaster, Business Administration; Health Sector Management2009 — 2011
- University of Rhode IslandDoctor of Pharmacy, Pharmacy1997 — 2003
Skills & more
Hospitals4Employee Training4Pharmaceutical Sales14Segmentation5Market Research6Strategy32Cross-functional Team Leadership43Oncology3Sales Effectiveness11Sales Operations17Leadership20Account Management6
+7 more
ManagementBusiness DevelopmentStrategic PlanningManaged CareSales ManagementProduct LaunchPharmaceutical IndustryLanguages English
From Rhonda's professional profile.
Same school
Also attended Duke University - The Fuqua School of Business165
David BlivinMANAGING PARTNER at Cottonwood Technology FundVinnie McSweeneyInvestor at OpenView Venture PartnersBrooke BalcomBoard Member at CincyTechChad L. SummeBoard Member at CincyTechMatias BarberoVenture Partner at FJ LabsTracie RotterPartner, Platform at Lux Capital
+ 159 more
Also attended University of Rhode Island20
Job SimonVenture Partner and CTO at Monta Vista CapitalScott FrechetteInvestor at Third Rock VenturesDave BarrettSenior Advisory Partner at Polaris PartnersNicole GenzardiInvestor at Silversmith Capital PartnersCollin McCollAnalyst at First Bight VenturesEric RyanObvious Champion at Obvious Ventures
+ 14 more
Shared employers
Also worked at Eli Lilly and Company69
David MollerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock VenturesMark LevinRetired Founding Partner at Third Rock VenturesCarlos PayaVenture Partner at Ysios CapitalKjersti FrognerInvestor at Almi InvestMilla KoistinahoPartner, Innovestor Life Science at Innovestor Ventures
+ 63 more
Colleagues at Takeda Ventures
Akiko Amakawa
CEO Chief of Staff at Takeda Ventures
Andrew S. Plump
Director - President, Research & Development at Takeda Ventures
Asuka Miyabashira
President, Japan Pharma Business Unit at Takeda Ventures
Awny Farajallah
Chief Medical Officer at Takeda Ventures
Christophe Weber
President and CEO, Representative Director at Takeda Ventures
Elaine Shannon
President, Global Supply & Quality at Takeda Ventures
Gabriele Ricci
Chief Data & Technology Officer at Takeda Ventures
Giles Platford
President, International Business Unit at Takeda Ventures